Health Catalyst (NASDAQ: HCAT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Health Catalyst (NASDAQ: HCAT) through any online brokerage.
The latest price target for Health Catalyst (NASDAQ: HCAT) was reported by Goldman Sachs on Thursday, May 26, 2022. The analyst firm set a price target for 37.00 expecting HCAT to rise to within 12 months (a possible 114.24% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Health Catalyst (NASDAQ: HCAT) is $17.27 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Health Catalyst.
Health Catalyst’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Health Catalyst.
Health Catalyst is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.